Preclinical Studies of Novel Targeted Therapies
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference150 articles.
1. Molecular mechanisms of novel therapeutic approaches for multiple myeloma;Hideshima;Nat Rev Cancer,2002
2. Advances in biology of multiple myeloma: clinical applications;Hideshima;Blood,2004
3. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets;Hideshima;Nat Rev Cancer,2007
4. Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells;Chauhan;J Exp Med,1995
5. Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production;Costes;Br J Haematol,1998
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group;Journal of Clinical Oncology;2023-06-20
2. Biological Background of Resistance to Current Standards of Care in Multiple Myeloma;Cells;2019-11-13
3. DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma;Biochemical and Biophysical Research Communications;2018-01
4. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells;International Journal of Hematology;2017-01-02
5. Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease;Clinical Cancer Research;2014-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3